Macular Degeneration
278
19
24
168
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
61 trials with published results (22%)
Research Maturity
168 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.7%
38 terminated out of 278 trials
81.6%
-5.0% vs benchmark
20%
56 trials in Phase 3/4
36%
61 of 168 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 168 completed trials
Clinical Trials (278)
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Study of New Mutations in Cone Disorders
Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Ocular Imaging Study Using Advanced OCT
A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)
Artificial Intelligence-assisted Diagnosis in Ophthalmology
Factors in Learning And Plasticity: Healthy Vision
Factors in Learning And Plasticity: Macular Degeneration
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration
Learning Study: Improving Vision in Adults With Macular Degeneration
Natural History Study of Inherited Retinal Diseases
Ranibizumab and Reduced Fluence PDT for AMD
A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Scotoma Perimetry Oculomotor Training